Literature DB >> 16178499

Common variable immunodeficiency: test indications and interpretations.

Catherine R Weiler1, Jennifer L Bankers-Fulbright.   

Abstract

Common variable immunodeficiency (CVID) is a primary immunodeficiency disorder that can present with multiple phenotypes, all of which are characterized by hypogammaglobulinemia, in a person at any age. A specific genetic defect that accounts for all CVID phenotypes has not been identified, and it is likely that several distinct genetic disorders with similar clinical presentations are responsible for the observed variation. In this review, we summarize the known genetic mutations that give rise to hypogammaglobulinemia and how these gene products affect normal or abnormal B-cell development and function, with particular emphasis on CVID. Additionally, we describe specific phenotypic and genetic laboratory tests that can be used to diagnose CVID and provide guidelines for test interpretation and subsequent therapeutic intervention.

Entities:  

Mesh:

Year:  2005        PMID: 16178499     DOI: 10.4065/80.9.1187

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  6 in total

1.  Common variable immunodeficiency-associated myelitis: report of treatment with infliximab.

Authors:  N Kumar; J B Hagan; R S Abraham; A J Aksamit
Journal:  J Neurol       Date:  2008-07-21       Impact factor: 4.849

2.  Genetic polymorphism study of regulatory B cell molecules and cellular immunity function in an adult patient with Common Variable Immunodeficiency.

Authors:  A Sarantopoulos; K Tselios; P Skendros; D Bougiouklis; I Theodorou; P Boura
Journal:  Hippokratia       Date:  2008-07       Impact factor: 0.471

3.  A novel syndrome of congenital sideroblastic anemia, B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD).

Authors:  Daniel H Wiseman; Alison May; Stephen Jolles; Philip Connor; Colin Powell; Matthew M Heeney; Patricia J Giardina; Robert J Klaassen; Pranesh Chakraborty; Michael T Geraghty; Nathalie Major-Cook; Caroline Kannengiesser; Isabelle Thuret; Alexis A Thompson; Laura Marques; Stephen Hughes; Denise K Bonney; Sylvia S Bottomley; Mark D Fleming; Robert F Wynn
Journal:  Blood       Date:  2013-04-03       Impact factor: 22.113

4.  Late Onset Combined Immunodeficiency Presenting with Recurrent Pneumocystis jiroveci Pneumonia.

Authors:  Ilias Papakonstantinou; Ioannis G Baraboutis; Lazaros Karnesis
Journal:  Case Rep Med       Date:  2014-03-31

Review 5.  Genetic defects in common variable immunodeficiency.

Authors:  O Kopecký; S Lukesová
Journal:  Int J Immunogenet       Date:  2007-08       Impact factor: 1.466

6.  Spectrum of primary immunodeficiency disorders in Sri Lanka.

Authors:  Nilhan Rajiva de Silva; Sepali Gunawardena; Damayanthi Rathnayake; Geethani Devika Wickramasingha
Journal:  Allergy Asthma Clin Immunol       Date:  2013-12-27       Impact factor: 3.406

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.